285: CRISPR history, biotech struggles, & a big week for deals
The Readout Loud
Approval of CRISPR Gene Editing Medicine for Sickle Cell Disease
This chapter discusses the approval of a new medicine, Cass Jevy, developed through CRISPR gene editing technology, for the treatment of sickle cell disease. It explores the significance of this development and explains the treatment process for patients.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
